Aqua Bio Technology — Earnings Release 2021

Aug 25, 2021

Aqua Bio Technology ASA - Result for first half year 2021

Aqua Bio Technology ASA - Result for first half year 2021

25.8.2021 08:45:01 CEST | Aqua Bio Technology ASA | Additional regulated

information required to be disclosed under the laws of a member state

First half year highlights - ready for rollout in the markets:

* Aqua Bio Technology (ABT) has signed distribution agreements for Norway,

Denmark, New Zealand and Australia for distribution of Moana and B Natural.

* Hydrafacial announced a partner agreement with Restorsea and the launch of

the Restorsea Lip Fix Kit based on Aquabeautine XL.

* Completion of second payment for exclusive world-wide rights for the Moana

Skincare brand.

* First order for Moana Skincare from DBK Pharmaceuticals S.A.E. confirmed.

* Confirmation from Al Dawaa Pharmacies that they are ready to distribute Moana

Skincare to pharmacies in Saudi Arabia after registration with the

authorities, starting with 50 pharmacies.

* Private placement in Q2 provided the company with approximately NOK 15

million.

* Launched 3 new trading platforms for Seiðr, Seiðr Clinique and B Natural,

respectively.

* Launched new website for ABT and B2B for distributors.

* Launched 44 new natural skincare products and three new skincare series, with

a high content of natural and active ingredients (11 Sei?r, 28 Sei?r

clinique, 15 products B Natural).

* Improvement of revenues in the first half of 2021 vs the same period in 2020.

* Major investments made to support and secure the production and launch of

ABT's new natural skincare products.

* Significantly increased activity from Restorsea, which has global rights to

ABT's patented and key ingredient Aquabeautine XL.

* The pandemic has affected ABT's producers, suppliers and distributors, but

the vaccination rate in various countries is reopening several of the

markets.

The company's revenues in the first half of 2021 were NOK 0.7 million against

NOK 0.3 million in the same period last year. About 30% of the income in the

period was royalty income from the collaboration with American Restorsea. Other

income was from the sale of skincare products. Cost of goods related to skincare

products amounted to NOK 1.0 million in the first half of the year, compared

with almost NOK 0.6 million in the same period last year. The company's

operating costs (excluding cost of goods) were NOK 8.1 million in the first half

of 2021. In the same period last year, operating costs were NOK 7.2 million.

EBITDA for the first half of 2021 was NOK -8.4 million, which is weaker compared

with the corresponding period last year, when EBITDA was NOK -7.5 million. ABT's

profit after tax was NOK -9.4 million, compared with NOK -6.4 million in the

first half of 2020.

The equity ratio at the end of the first half of the year was 50.50%, compared

to 22.60% after the first half of 2020.

* * *

For further information, please contact CEO Håvard Lindstrøm mobile phone 0047

941 32 288.

Aqua Bio Technology (ABT) is developing and commercializing sustainable

biotechnology for use in skincare products. ABT's cosmetics ingredients are

highly effective and they provide the cosmetics industry with natural

alternatives to traditional ingredients. ABT is also marketing and distributing

natural skincare products developed by partners towards consumers and

professional users. ABT's focus on commercialization and development of natural

ingredients and natural skincare products has been, and will continue to be, an

important part of the Company's strategy going forward. Aqua Bio Technology is

listed on the Euronext Expand market of the Oslo Stock Exchange. This

information is such that Aqua Bio Technology ASA is required to disclose in

accordance with the EU Market Abuse Regulation, and is subject to the disclosure

requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section

of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

* Håvard Lindstrøm, 004794132288, hl@aquabiotech.no

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable

biotechnology for use in skin care products. ABT's cosmetics ingredients are

highly effective and they provide the cosmetics industry with natural

alternatives to traditional ingredients. ABT is also marketing and distributing

natural skin care products developed by partners towards consumers and

professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -

https://kommunikasjon.ntb.no/ir-files/17847556/797/1037/Download%20announcement%

20as%20PDF.pdf

ABT halvarsrapport 25 august 2021.pdf -

https://kommunikasjon.ntb.no/ir-files/17847556/797/1036/ABT%20halvarsrapport%202

5%20august%202021.pdf